Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Oleanolic acid, a naturally occurring triterpenoid found in a variety of plants (notably olives), has garnered scientific interest for its potential role in managing Metabolic Syndrome (MetS). Metabolic Syndrome is a cluster of conditions, including insulin resistance, obesity, dyslipidemia, and hypertension, that increase cardiovascular risk. Preclinical studies (mainly in animal models) have demonstrated that oleanolic acid can improve insulin sensitivity, reduce blood glucose levels, and ameliorate lipid profiles. These effects are thought to be mediated by modulation of signaling pathways, such as the inhibition of NF-κB-mediated inflammation, enhancement of AMPK signaling, and improved expression of glucose transporters.

A handful of small-scale human studies and clinical trials have begun to emerge, showing that oleanolic acid supplementation may contribute to improved glycemic control and lipid metabolism in individuals with features of MetS. However, the bulk of evidence remains preclinical, with human studies limited in number, size, and duration. No major clinical guidelines currently endorse oleanolic acid for Metabolic Syndrome, and more robust, long-term trials are required to confirm efficacy and safety. Thus, while there is some scientific validation and biological plausibility supporting its use, the evidence is moderate (rated 3/5), and its use should be considered investigational rather than established therapy.

More about oleanolic acid
More about Metabolic Syndrome

Other ingredients used for Metabolic Syndrome

Other health conditions supported by oleanolic acid

Products containing oleanolic acid